Cargando…
Rationale and design of the CAPAMIS study: Effectiveness of pneumococcal vaccination against community-acquired pneumonia, acute myocardial infarction and stroke
BACKGROUND: The 23-valent polysaccharide pneumococcal vaccine (PPV-23) is recommended for elderly and high-risk people, although its effectiveness is controversial. Some studies have reported an increasing risk of acute vascular events among patients with pneumonia, and a recent case-control study h...
Autores principales: | Vila-Corcoles, Angel, Hospital-Guardiola, Inmaculada, Ochoa-Gondar, Olga, de Diego, Cinta, Salsench, Elisabet, Raga, Xavier, Fuentes-Bellido, Cruz M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2822825/ https://www.ncbi.nlm.nih.gov/pubmed/20085658 http://dx.doi.org/10.1186/1471-2458-10-25 |
Ejemplares similares
-
Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up
por: Vila-Corcoles, Angel, et al.
Publicado: (2012) -
Utilidad de la escala de severidad modificada CRB75 en el manejo del paciente anciano con neumonía adquirida en la comunidad()
por: Ochoa Gondar, Olga, et al.
Publicado: (2013) -
Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
por: Vila-Corcoles, Angel, et al.
Publicado: (2010) -
Drug-resistance in Streptococcus pneumoniae isolates among Spanish middle aged and older adults with community-acquired pneumonia
por: Vila-Corcoles, Angel, et al.
Publicado: (2009) -
Pneumococcal vaccination coverages by age, sex and specific underlying risk conditions among middle-aged and older adults in Catalonia, Spain, 2017
por: Vila-Córcoles, Angel, et al.
Publicado: (2019)